194 related articles for article (PubMed ID: 9528953)
1. Insulin-like growth factor-binding protein-5 is cleaved by physiological concentrations of thrombin.
Zheng B; Clarke JB; Busby WH; Duan C; Clemmons DR
Endocrinology; 1998 Apr; 139(4):1708-14. PubMed ID: 9528953
[TBL] [Abstract][Full Text] [Related]
2. Protease-resistant form of insulin-like growth factor-binding protein 5 is an inhibitor of insulin-like growth factor-I actions on porcine smooth muscle cells in culture.
Imai Y; Busby WH; Smith CE; Clarke JB; Garmong AJ; Horwitz GD; Rees C; Clemmons DR
J Clin Invest; 1997 Nov; 100(10):2596-605. PubMed ID: 9366575
[TBL] [Abstract][Full Text] [Related]
3. Control of insulin-like growth factor binding protein-5 protease synthesis and secretion by human fibroblasts and porcine aortic smooth muscle cells.
Moralez A; Busby WH; Clemmons D
Endocrinology; 2003 Jun; 144(6):2489-95. PubMed ID: 12746311
[TBL] [Abstract][Full Text] [Related]
4. Inflammation-related neutrophil proteases, cathepsin G and elastase, function as insulin-like growth factor binding protein proteases.
Gibson TL; Cohen P
Growth Horm IGF Res; 1999 Aug; 9(4):241-53. PubMed ID: 10512690
[TBL] [Abstract][Full Text] [Related]
5. Regulation of insulin-like growth factor-binding protein-5 by insulin-like growth factor I and interleukin-1alpha in ovine articular chondrocytes.
Sunic D; McNeil JD; Rayner TE; Andress DL; Belford DA
Endocrinology; 1998 May; 139(5):2356-62. PubMed ID: 9564845
[TBL] [Abstract][Full Text] [Related]
6. Insulin-like growth factor binding protein-5 (IGFBP-5) interacts with thrombospondin-1 to induce negative regulatory effects on IGF-I actions.
Moralez AM; Maile LA; Clarke J; Busby WH; Clemmons DR
J Cell Physiol; 2005 May; 203(2):328-34. PubMed ID: 15700281
[TBL] [Abstract][Full Text] [Related]
7. Properties of an insulin-like growth factor-binding protein-4 protease that is secreted by smooth muscle cells.
Parker A; Gockerman A; Busby WH; Clemmons DR
Endocrinology; 1995 Jun; 136(6):2470-6. PubMed ID: 7538463
[TBL] [Abstract][Full Text] [Related]
8. Characterization and determination of the relative abundance of two types of insulin-like growth factor binding protein-5 proteases that are secreted by human fibroblasts.
Nam TJ; Busby WH; Clemmons DR
Endocrinology; 1996 Dec; 137(12):5530-6. PubMed ID: 8940380
[TBL] [Abstract][Full Text] [Related]
9. Effect of glucose on insulin-like growth factor binding protein-4 proteolysis.
Jacot TA; Clemmons DR
Endocrinology; 1998 Jan; 139(1):44-50. PubMed ID: 9421396
[TBL] [Abstract][Full Text] [Related]
10. A protease-resistant form of insulin-like growth factor (IGF) binding protein 4 inhibits IGF-1 actions.
Rees C; Clemmons DR; Horvitz GD; Clarke JB; Busby WH
Endocrinology; 1998 Oct; 139(10):4182-8. PubMed ID: 9751498
[TBL] [Abstract][Full Text] [Related]
11. Human fibroblasts secrete a serine protease that cleaves insulin-like growth factor-binding protein-5.
Nam TJ; Busby WH; Clemmons DR
Endocrinology; 1994 Oct; 135(4):1385-91. PubMed ID: 7523096
[TBL] [Abstract][Full Text] [Related]
12. Expression and characterization of a serine protease that preferentially cleaves insulin-like growth factor binding protein-5.
Hou J; Clemmons DR; Smeekens S
J Cell Biochem; 2005 Feb; 94(3):470-84. PubMed ID: 15534875
[TBL] [Abstract][Full Text] [Related]
13. Porcine aortic smooth muscle cells secrete a serine protease for insulin-like growth factor binding protein-2.
Gockerman A; Clemmons DR
Circ Res; 1995 Apr; 76(4):514-21. PubMed ID: 7534656
[TBL] [Abstract][Full Text] [Related]
14. Evidence that the interaction between insulin-like growth factor (IGF)-II and IGF binding protein (IGFBP)-4 is essential for the action of the IGF-II-dependent IGFBP-4 protease.
Qin X; Byun D; Lau KH; Baylink DJ; Mohan S
Arch Biochem Biophys; 2000 Jul; 379(2):209-16. PubMed ID: 10898936
[TBL] [Abstract][Full Text] [Related]
15. Evidence for a novel insulin-like growth factor (IGF)-dependent protease regulating IGF-binding protein-4 in dermal fibroblasts.
Fowlkes J; Freemark M
Endocrinology; 1992 Nov; 131(5):2071-6. PubMed ID: 1385096
[TBL] [Abstract][Full Text] [Related]
16. Binding of insulin-like growth factor (IGF)-binding protein-5 to smooth-muscle cell extracellular matrix is a major determinant of the cellular response to IGF-I.
Parker A; Rees C; Clarke J; Busby WH; Clemmons DR
Mol Biol Cell; 1998 Sep; 9(9):2383-92. PubMed ID: 9725901
[TBL] [Abstract][Full Text] [Related]
17. IGF-I differentially regulates IGF-binding protein expression in primary mammary fibroblasts and epithelial cells.
Fleming JM; Leibowitz BJ; Kerr DE; Cohick WS
J Endocrinol; 2005 Jul; 186(1):165-78. PubMed ID: 16002546
[TBL] [Abstract][Full Text] [Related]
18. Intact insulin-like growth factor binding protein-5 (IGFBP-5) associates with bone matrix and the soluble fragments of IGFBP-5 accumulated in culture medium of neonatal mouse calvariae by parathyroid hormone and prostaglandin E2-treatment.
Hakeda Y; Kawaguchi H; Hurley M; Pilbeam CC; Abreu C; Linkhart TA; Mohan S; Kumegawa M; Raisz LG
J Cell Physiol; 1996 Feb; 166(2):370-9. PubMed ID: 8591997
[TBL] [Abstract][Full Text] [Related]
19. Differential expression and biological effects of insulin-like growth factor-binding protein-4 and -5 in vascular smooth muscle cells.
Duan C; Clemmons DR
J Biol Chem; 1998 Jul; 273(27):16836-42. PubMed ID: 9642243
[TBL] [Abstract][Full Text] [Related]
20. Regulation of insulin-like growth factor (IGF) binding protein-2 synthesis and degradation by platelet-derived growth factor and the IGFs is enhanced by serum deprivation in vascular smooth muscle cells.
Cohick WS; Gockerman A; Clemmons DR
J Cell Physiol; 1995 Jul; 164(1):187-96. PubMed ID: 7540619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
